日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Analysis of the transcriptomic and metabolomic landscape of prostate cancer with different anatomical origins using snFLARE-seq and mxFRIZNGRND

利用snFLARE-seq和mxFRIZNGRND分析不同解剖起源的前列腺癌的转录组和代谢组图谱

He, Dongyin; Hu, Haoran; Xiao, Kai; Zhang, Yuhang; Cheng, Yongbing; Jiao, Shaozhuo; Hao, Yimei; Cai, Yuanyuan; Liu, Ziqun; Yan, Xinran; Chen, Qinsheng; Mu, Xiyan; Wang, Qi; Peng, Shan; Sang, Guoqin; Zhi, Xiaoling; Chang, Yanxia; Ye, Qing; Yang, Yuyao; Che, Meixia; Huang, Shengsong; Guo, Hongqian; Chen, Luonan; Tang, Huiru; Qiu, Xuefeng; Li, Zhenfei

GSTA1 deficiency drives neuroendocrine differentiation via TNFRSF13B/c-FOS/CHGA axis in prostate cancer

GSTA1 缺陷通过 TNFRSF13B/c-FOS/CHGA 轴驱动前列腺癌的神经内分泌分化

Qian, Jiajun; Luo, Yang; Fu, Yao; Diao, Wenli; Ding, Qiubo; Chen, Wei; Qiu, Xuefeng; Guo, Hongqian

Preclinical activity of SHR-A1921, a novel antibody-drug conjugate targeting trophoblast cell-surface antigen2 (Trop-2) in prostate cancer

SHR-A1921是一种新型抗体药物偶联物,靶向滋养层细胞表面抗原2 (Trop-2),在前列腺癌中的临床前活性

Wang, Binyu; Xu, Qiuya; Peng, Shan; Han, Zheng; Huang, Haifeng; Guo, Hongqian; Qiu, Xuefeng

Modified water vapor thermal therapy for large-volume benign prostatic hyperplasia

改良型水蒸气热疗法治疗大体积良性前列腺增生

Lu, Qun; Zhu, Guanchen; Liu, Jun; Huang, Haifeng; Zhang, Fan; Qiu, Xuefeng; Xu, Linfeng; Guo, Hongqian

Electroacupuncture in Patients With Early Urinary Incontinence After Radical Prostatectomy: A Randomized Clinical Trial

电针疗法治疗根治性前列腺切除术后早期尿失禁患者:一项随机临床试验

Niu, Jiahui; Wang, Yang; Wang, Yujuan; Shi, Jingyan; Liang, Jing; Zhao, Xiaozhi; Xu, Tianshu; Guo, Hongqian; Qiu, Xuefeng

DECIPHER-PRAD: an advanced fragmentomics-based cell-free DNA assay for prostate cancer early detection

DECIPHER-PRAD:一种基于片段组学的先进无细胞DNA检测方法,用于前列腺癌的早期检测

Zhang, Shun; Zhu, Guanchen; Xu, Linfeng; Zhang, Qing; Qiu, Xuefeng; Bao, Hua; Wu, Min; Zhao, Xiaotian; Ding, Tao; Wang, Fufeng; Chang, Shuang; Shao, Yang; Zhuang, Junlong; Guo, Hongqian

The expression of prostate-specific membrane antigen in intraductal carcinoma of the prostate

前列腺导管内癌中前列腺特异性膜抗原的表达

Han, Zheng; Wang, Binyu; Peng, Shan; Fu, Yao; Yang, Fengjiao; Ai, Shuyue; Wang, Feng; Zhuang, Junlong; Guo, Hongqian; Qiu, Xuefeng

The lncRNA MIR22HG suppresses prostate cancer cell proliferation, migration, and epithelial-mesenchymal transition via the miR-4428/PCDH9 axis.

lncRNA MIR22HG 通过 miR-4428/PCDH9 轴抑制前列腺癌细胞增殖、迁移和上皮-间质转化

Li Ansu, Sun Wu, Shao Shihe, Qiu Xuefeng, Hu Jianpeng, Cui Feilun

Patient-derived organoids based on targeted biopsy of primary prostate cancer: development, identification, and drug screening

基于原发性前列腺癌靶向活检的患者来源类器官:构建、鉴定和药物筛选

Qian, Jiajun; Peng, Shan; Gao, Jie; Fu, Yao; Huang, Haifeng; Wu, Cheng; Gan, Weidong; Qiu, Xuefeng; Guo, Hongqian

A student trained convolutional neural network competing with a commercial AI software and experts in organ at risk segmentation

一个由学生训练的卷积神经网络与商业人工智能软件和器官危及区域分割专家展开竞争

Bürkle, Sophia L; Kuhn, Dejan; Fechter, Tobias; Radicioni, Gianluca; Hartong, Nanna; Freitag, Martin T; Qiu, Xuefeng; Karagiannis, Efstratios; Grosu, Anca-Ligia; Baltas, Dimos; Zamboglou, Constantinos; Spohn, Simon K B